← Leaderboards
Michael James Gough
Providence Portland Medical Center
$5,824,686
Attributed
$5,824,686
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $988.1K · FY2014–24$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,824,686 · 3
By mechanism
R01$5,405,046 · 2
R21$419,640 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneResearch DesignSamplingEnvironmentRadiation TherapyT Cell ResponseCancer CellPre-Clinical ModelTumorResponsePreventT-LymphocyteMalignant Neoplasm Of PancreasImmunotherapyCellsImmunogenicDendritic CellsRegulationBioinformaticsMalignant NeoplasmsTumor ImmunityLinkImmune ResponseDose Fractionation
Grant awards (17)
Rewiring the myeloid cell response to adjuvants to improve tumor control$358,566
R01 · FY2024 · CA · contact PI
DNASE1L3 regulation of anti-tumor immune responses following radiation therapy$185,422
R21 · FY2024 · CA · contact PI
High dose radiation therapy to direct immune responses to pancreatic cancer$384,038
R01 · FY2023 · CA · contact PI
Rewiring the myeloid cell response to adjuvants to improve tumor control$369,889
R01 · FY2023 · CA · contact PI
DNASE1L3 regulation of anti-tumor immune responses following radiation therapy$234,218
R21 · FY2023 · CA · contact PI
High dose radiation therapy to direct immune responses to pancreatic cancer$384,038
R01 · FY2022 · CA · contact PI
Rewiring the myeloid cell response to adjuvants to improve tumor control$369,889
R01 · FY2022 · CA · contact PI
High dose radiation therapy to direct immune responses to pancreatic cancer$391,875
R01 · FY2021 · CA · contact PI
Rewiring the myeloid cell response to adjuvants to improve tumor control$377,438
R01 · FY2021 · CA · contact PI
High dose radiation therapy to direct immune responses to pancreatic cancer$391,875
R01 · FY2020 · CA · contact PI
Rewiring the myeloid cell response to adjuvants to improve tumor control$377,438
R01 · FY2020 · CA · contact PI
High dose radiation therapy to direct immune responses to pancreatic cancer$391,875
R01 · FY2019 · CA · contact PI
High dose radiation therapy to direct immune responses to pancreatic cancer$321,625
R01 · FY2018 · CA · contact PI
High dose radiation therapy to direct immune responses to pancreatic cancer$321,625
R01 · FY2017 · CA · contact PI
High dose radiation therapy to direct immune responses to pancreatic cancer$321,625
R01 · FY2016 · CA · contact PI
High dose radiation therapy to direct immune responses to pancreatic cancer$321,625
R01 · FY2015 · CA · contact PI
High dose radiation therapy to direct immune responses to pancreatic cancer$321,625
R01 · FY2014 · CA · contact PI